InvestorsHub Logo
Followers 21
Posts 1400
Boards Moderated 0
Alias Born 03/03/2021

Re: Poor Man - post# 497847

Monday, 07/25/2022 2:24:05 PM

Monday, July 25, 2022 2:24:05 PM

Post# of 692184
1. IP protection. Clearly, you can't trust anyone with this kind of thing.
2. Stability of CDMO from other operations. So, if there are up and down waves of development; or new products, CDMO will be strong and sound... won't have to shop for one and risk IP losses.
3. US/FDA kind of a lost cause, so by going UK route, perhaps MHRA prefers a contracted CDMO, and not one owned and operated by the same pharma company ??? I am not familiar with this part, but it makes sense.
4. She and whomever owns Toucan might benefit, so, duh, AMAZING businesswoman running our company !!

All IMHO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News